| 25 |
NGeneBio Gets CE-IVD Mark for HLA Typing Assay |
2021.11.25 |
Admin |
| 24 |
NGeneBio nominated for the Best oral/poster award at LMCE 2021 |
2021.10.15 |
Admin |
| 23 |
Quarterly Newsletter_3Q 2021 |
2021.09.29 |
Admin |
| 22 |
[KR] NGeneBio and CNUHH will build a cloud-based genome analysis platform |
2021.09.08 |
Admin |
| 21 |
[KR] NGeneBio gained approval ‘BRCAaccuTEST PLUS’ from KFDA |
2021.08.23 |
Admin |
| 20 |
[KR] NGeneBio registered a patent for the analysis algorithm of cancer-related genetic variants |
2021.06.30 |
Admin |
| 19 |
Quarterly Newsletter_2Q 2021 |
2021.06.22 |
Admin |
| 18 |
[KR] Molecular epidemiological study of metastatic prostate cancer with Asan Medical Center |
2021.05.28 |
Admin |
| 17 |
NGeneBio Raises $11M |
2019.02.25 |
Admin |
| 16 |
NGeneBio Receives CE Mark for BRCA Test Panel and Data Analysis Software |
2017.10.12 |
Admin |
